Pre-Op DAAs Enable for HCV-Infected Kidney Transplants in Tiny Trial
A truncated direction of glecaprevir-pibrentasvir (Mavyret) prophylaxis started prior to transplant allowed patients without hepatitis C virus (HCV) infection to safely bag kidneys from HCV-particular donors, a small single-center seek stumbled on. In all, 10 transplants from HCV-particular donors to…